《美股業績》美高梅集團首季收入勝預期 中國業務恢復盈利
美高梅(MGM.US)公布,今年首季收入按年增35.8%至38.7億美元,高於預期的36.1億美元。剔除一次性項目後,每股收益為44美仙,高於預期的6美仙。
美高梅所有部門收入均見增長,賭博收入增長32%至18.8億美元。
亞洲方面,受惠疫情後重新開關,美高梅中國首季收入增長130%至6.18億美元,較疫情前、2019年首季下跌16%,經調整的物業EBITDAR按年扭虧,賺1.69億美元;經調整的物業EBITDAR利潤率27.4%,2019年首季為26.3%。
美高梅稱,美高梅中國已恢復盈利,目前計劃興建日本綜合渡假村,尋求亞洲擴張。
該股盤後跌0.2%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.